• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-05-22

  This study demonstrates that phenothiazines, including perphenazine, enhance macrophage-mediated antibacterial responses by inducing reactive oxygen species (ROS) and autophagy. These findings advance host-directed therapy strategies against intracellular pathogens, offering a promising avenue for combating antibiotic resistance.

• Azilsartan Medoxomil Monopotassium: Precision in Hypertensio

  2026-05-22

  Azilsartan medoxomil monopotassium (TAK 491) stands out for its sustained, selective AT1 antagonism, empowering advanced blood pressure and cardiovascular disease models. This article delivers actionable workflows, troubleshooting guidance, and real-world protocol enhancements for maximizing research reproducibility with this potent ARB.

• Ziprasidone Augmentation in Escitalopram-Treated Anxious Dep

  2026-05-21

  This article examines a pivotal study investigating whether ziprasidone augmentation improves outcomes for patients with major depressive disorder (MDD) and high anxiety already receiving escitalopram. The findings refine expectations for combination therapy in antidepressant research, highlighting the nuanced effects on depressive and anxiety symptoms.

• Ribonuclease R (20 U/μL): Enabling Reliable Circular RNA Enr

  2026-05-21

  Ribonuclease R (RNase R) (20 U/μL) from APExBIO delivers robust and selective linear RNA degradation, transforming the accuracy of circular RNA enrichment in cancer and immunology research. This article walks through advanced, evidence-backed workflows, troubleshooting strategies, and data-driven protocol enhancements to empower reproducible circRNA analysis in complex biological systems.

• Gemcitabine HCl: Advanced Protocols for Pancreatic Tumor Mod

  2026-05-20

  Gemcitabine HCl enables high-precision pancreatic cancer research, especially when paired with innovative multianimal MRI workflows. This article decodes practical assay setups, troubleshooting, and evidence-backed enhancements for tumor growth suppression and apoptosis induction studies.

• EdU Flow Cytometry Assay Kits (Cy3): Streamlining S-Phase An

  2026-05-20

  The EdU Flow Cytometry Assay Kits (Cy3) empower researchers to achieve precise, denaturation-free DNA synthesis detection for high-content cell cycle and genotoxicity studies. By leveraging click chemistry, these kits outperform traditional BrdU assays, facilitating multiplexing and advanced pharmacodynamic evaluations.

• Dasatinib (BMS-354825): Precision Kinase Inhibition in EMT a

  2026-05-19

  Explore how Dasatinib (BMS-354825) advances kinase-driven malignancy research by dissecting its impact on EMT, cancer stemness, and protocol optimization. This in-depth guide delivers unique insights for translational scientists leveraging Dasatinib in diverse oncological models.

• Functionally Selective 5-HT1A Agonists for Non-Opioid Pain R

  2026-05-19

  The reference study reports the discovery of ST171, a novel, functionally selective serotonin 5-HT1A receptor agonist with potent antinociceptive effects and minimal sedative side effects. By leveraging high-content screening of FDA-approved drugs and structural analyses, the research highlights new avenues for developing safer, non-opioid analgesics.

• ATRX Loss Sensitizes Glioma to Selective PDGFR Inhibition

  2026-05-18

  This study demonstrates that ATRX-deficient high-grade glioma cells are particularly vulnerable to receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings highlight the importance of ATRX mutation status as a biomarker for targeted therapy and inform the design of future cancer research workflows.

• JHU-083: 6-diazo-5-oxo-L-norleucine Precursor in Neuro-Redox

  2026-05-18

  JHU-083 stands out as a potent, selective glutaminase antagonist for precise manipulation of glutamate and glutathione pathways in experimental cerebral malaria and neurological disease models. This article details actionable workflows, advanced troubleshooting, and how JHU-083 enables reproducibility and pathophysiological relevance in glutamate excitotoxicity and redox biology research.

• Mitoxantrone HCl: Advanced DNA Topoisomerase II Inhibitor Wo

  2026-05-17

  Mitoxantrone HCl empowers researchers with dual-action capabilities—inducing DNA damage and uniquely disrupting estrogen receptor function. This guide delivers data-backed protocol enhancements, troubleshooting insights, and new avenues for resistance modeling, positioning APExBIO's Mitoxantrone HCl as an essential tool for high-impact cancer and immunology research.

• CDK4/6 and BET Inhibition Synergize via Wnt/β-Catenin Modula

  2026-05-16

  Gu et al. reveal that dual inhibition of CDK4/6 and BET proteins synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth and reverses EMT by targeting the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight clarifies unexpected pro-metastatic effects of CDK4/6 inhibition and informs combinatorial therapeutic strategies.

• Dexamethasone: Glucocorticoid Anti-Inflammatory in Bench Wor

  2026-05-15

  Dexamethasone (DHAP) from APExBIO empowers precise, reproducible control of immune modulation and neuroinflammation in both cellular and animal models. Explore data-driven protocols, troubleshooting strategies, and comparative workflow advantages that unlock the full translational potential of this glucocorticoid anti-inflammatory.

• Pregnenolone-16α-carbonitrile Modulates Hippocampal CYP to P

  2026-05-15

  This study reveals that Pregnenolone-16α-carbonitrile selectively suppresses cytochrome P450 enzymes in the hippocampus via glucocorticoid receptor pathways, protecting against phenytoin-induced neurotoxicity in mice. The findings redefine the neuropharmacological roles of PCN and highlight distinct regulatory mechanisms compared to hepatic pathways, with implications for safer antiepileptic drug therapy.

• Biotin-16-UTP: Practical Guide for RNA Labeling and Detectio

  2026-05-14

  Biotin-16-UTP addresses the need for efficient, specific RNA labeling in workflows requiring RNA detection, purification, and interaction studies. It is best used in in vitro transcription protocols for generating biotinylated RNA, but is not intended for clinical or diagnostic applications. Researchers should follow storage and handling recommendations to maintain reagent integrity.

448 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page